Annelie Clurman
Overview
Explore the profile of Annelie Clurman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dai A, Adintori P, Funnell T, Jogia W, Fei T, Waters N, et al.
bioRxiv
. 2024 Oct;
PMID: 39463943
Intestinal microbiota composition is implicated in several diseases; understanding the factors that influence it are key to elucidating host-commensal interactions and to designing microbiome-targeted therapies. We quantified how diet influences...
2.
Smith M, Dai A, Ghilardi G, Amelsberg K, Devlin S, Pajarillo R, et al.
Nat Med
. 2022 Oct;
29(11):2954.
PMID: 36253610
No abstract available.
3.
Chhabra S, Szabo A, Clurman A, McShane K, Waters N, Eastwood D, et al.
Haematologica
. 2022 Sep;
108(1):250-256.
PMID: 36106394
No abstract available.
4.
Burgos da Silva M, Ponce D, Dai A, Devlin S, Gomes A, Moore G, et al.
Blood
. 2022 Aug;
140(22):2385-2397.
PMID: 35969834
Following allogeneic hematopoietic cell transplantation (allo-HCT), the gastrointestinal (GI) tract is frequently affected by acute graft-versus-host disease (aGVHD), the pathophysiology of which is associated with a dysbiotic microbiome. Since microbial...
5.
Andrlova H, Miltiadous O, Kousa A, Dai A, DeWolf S, Violante S, et al.
Sci Transl Med
. 2022 May;
14(646):eabj2829.
PMID: 35613281
Microbial diversity is associated with improved outcomes in recipients of allogeneic hematopoietic cell transplantation (allo-HCT), but the mechanism underlying this observation is unclear. In a cohort of 174 patients who...
6.
Smith M, Dai A, Ghilardi G, Amelsberg K, Devlin S, Pajarillo R, et al.
Nat Med
. 2022 Mar;
28(4):713-723.
PMID: 35288695
Anti-CD19 chimeric antigen receptor (CAR) T cell therapy has led to unprecedented responses in patients with high-risk hematologic malignancies. However, up to 60% of patients still experience disease relapse and...
7.
Miltiadous O, Waters N, Andrlova H, Dai A, Nguyen C, Burgos da Silva M, et al.
Blood
. 2022 Jan;
139(18):2758-2769.
PMID: 35061893
Low intestinal microbial diversity is associated with poor outcomes after allogeneic hematopoietic cell transplantation (HCT). Using 16S rRNA sequencing of 2067 stool samples and flow cytometry data from 2370 peripheral...
8.
Khan N, Lindner S, Gomes A, Devlin S, Shah G, Sung A, et al.
Blood
. 2021 Jan;
137(11):1527-1537.
PMID: 33512409
We previously described clinically relevant reductions in fecal microbiota diversity in patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT). Recipients of high-dose chemotherapy and autologous HCT (auto-HCT) incur similar antibiotic exposures...
9.
Pianko M, Devlin S, Littmann E, Chansakul A, Mastey D, Salcedo M, et al.
Blood Adv
. 2019 Jul;
3(13):2040-2044.
PMID: 31289031
Patients with multiple myeloma (MM) who achieve minimal residual disease (MRD) negativity after upfront treatment have superior outcomes compared with those who remain MRD Recently, associations have been shown between...